<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01130181</url>
  </required_header>
  <id_info>
    <org_study_id>VITdAL@ICU - 19022010</org_study_id>
    <nct_id>NCT01130181</nct_id>
  </id_info>
  <brief_title>VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients</brief_title>
  <acronym>VITdAL@ICU</acronym>
  <official_title>Correction of Vitamin D Deficiency in Critically Ill Patients: a Randomized, Double-blind, Placebo-controlled Trial (&quot;VITDAL@ICU&quot;)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harald Dobnig, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study hypothesis:

      High-dose vitamin D leads to a shorter hospital stay in critically ill patients

      Vitamin D deficient patients will be randomized to receive either 540,000 IU cholecalciferol
      or placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria

        -  Age ≥18 years

        -  expected ICU stay ≥48 hours

        -  vitamin D deficiency: 25(OH)D ≤ 20 ng/ml

        -  feasibility of study drug application via nasogastric tube in cases where oral food
           intake is not possible

      Exclusion criteria

        -  moribund patient expected to die within 24 hours

        -  hypercalcaemia (total calcium &gt;2.65 OR ion. calcium &gt;1.35 mmol/l)

        -  severely impaired gastrointestinal motility (ileus, residual gastric volume &gt; 400 ml)

        -  known history of recent kidney stones (≤ 1 year)

        -  known granulomatous diseases (tuberculosis, sarcoidosis)

        -  pregnancy

      Primary endpoint

        -  hospital stay (hours; starting from ICU admission) Secondary endpoints

        -  percentage of patients with 25(OH)D ≥ 30 ng/ml at day 7

        -  serum calcium; phosphorus; 25(OH)D; 1,25(OH)D; PTH; osteocalcin; bALP; TRAP; urinary
           calcium
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>maximum 6 months</time_frame>
    <description>The length of hospital stay will be compared between the two groups (starting from application of the study medication; end is defined as death of the patient or hospital discharge) Survivors and non-survivors will also be analysed separately. Stay in rehabilitation facilities will not be counted.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>25(OH)D levels</measure>
    <time_frame>maximum 6 months</time_frame>
    <description>serum 25(OH)D levels will be measured on day 0, 3 and 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calcium levels</measure>
    <time_frame>maximum 6 months</time_frame>
    <description>serum calcium levels will be measured on day 0, 3 and 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay starting from application of study medication</measure>
    <time_frame>until patient's death or referral to another ward</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of mechanical ventilation</measure>
    <time_frame>starting from application of study medication</time_frame>
    <description>duration of mechanical ventilation including CPAP/mask ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital mortality, 28-day mortality, 6 month-mortality</measure>
    <time_frame>maximum 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">480</enrollment>
  <condition>Critical Illness</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>loading dose of 540,000 IU of cholecalciferol via feeding tube or orally, then 5 monthly doses of 90,000 IU</description>
    <arm_group_label>Cholecalciferol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>herbal oil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  expected ICU stay ≥48 hours

          -  vitamin D deficiency: 25(OH)D ≤ 20 ng/ml

          -  feasibility of study drug application via nasogastric tube in cases where oral food
             intake is not possible

        Exclusion Criteria:

          -  moribund patient expected to die within 24 hours

          -  hypercalcaemia (total calcium &gt;2.65 OR ion. calcium &gt;1.35 mmol/l)

          -  severely impaired gastrointestinal motility (ileus, residual gastric volume &gt; 400 ml)

          -  known history of recent kidney stones (≤ 1 year)

          -  known granulomatous diseases (tuberculosis, sarcoidosis)

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harald Dobnig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med. 2009 Apr 30;360(18):1912-4. doi: 10.1056/NEJMc0809996. Erratum in: N Engl J Med. 2011 May 12;364(19):1882.</citation>
    <PMID>19403914</PMID>
  </reference>
  <reference>
    <citation>Lucidarme O, Messai E, Mazzoni T, Arcade M, du Cheyron D. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med. 2010 Sep;36(9):1609-11. doi: 10.1007/s00134-010-1875-8. Epub 2010 Apr 7.</citation>
    <PMID>20373095</PMID>
  </reference>
  <reference>
    <citation>Lee P, Nair P, Eisman JA, Center JR. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med. 2009 Dec;35(12):2028-32. doi: 10.1007/s00134-009-1642-x. Epub 2009 Sep 15. Review.</citation>
    <PMID>19756497</PMID>
  </reference>
  <reference>
    <citation>Mata-Granados JM, Vargas-Vasserot J, Ferreiro-Vera C, Luque de Castro MD, Pavón RG, Quesada Gómez JM. Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):452-5. doi: 10.1016/j.jsbmb.2010.03.078. Epub 2010 Apr 21.</citation>
    <PMID>20399267</PMID>
  </reference>
  <reference>
    <citation>Krishnan A, Ochola J, Mundy J, Jones M, Kruger P, Duncan E, Venkatesh B. Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care. 2010;14(6):R216. doi: 10.1186/cc9341. Epub 2010 Nov 26.</citation>
    <PMID>21110839</PMID>
  </reference>
  <reference>
    <citation>Amrein K, Venkatesh B. Vitamin D and the critically ill patient. Curr Opin Clin Nutr Metab Care. 2012 Mar;15(2):188-93. doi: 10.1097/MCO.0b013e32834f0027. Review.</citation>
    <PMID>22186356</PMID>
  </reference>
  <reference>
    <citation>Braun AB, Gibbons FK, Litonjua AA, Giovannucci E, Christopher KB. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2012 Jan;40(1):63-72. doi: 10.1097/CCM.0b013e31822d74f3.</citation>
    <PMID>21926604</PMID>
  </reference>
  <reference>
    <citation>Amrein K, Schnedl C, Berghold A, Pieber TR, Dobnig H. Correction of vitamin D deficiency in critically ill patients - VITdAL@ICU study protocol of a double-blind, placebo-controlled randomized clinical trial. BMC Endocr Disord. 2012 Nov 7;12:27. doi: 10.1186/1472-6823-12-27.</citation>
    <PMID>23134762</PMID>
  </reference>
  <reference>
    <citation>Amrein K, Zajic P, Schnedl C, Waltensdorfer A, Fruhwald S, Holl A, Purkart T, Wünsch G, Valentin T, Grisold A, Stojakovic T, Amrein S, Pieber TR, Dobnig H. Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit Care. 2014 Mar 24;18(2):R47. doi: 10.1186/cc13790.</citation>
    <PMID>24661739</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2010</study_first_submitted>
  <study_first_submitted_qc>May 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2010</study_first_posted>
  <last_update_submitted>May 23, 2014</last_update_submitted>
  <last_update_submitted_qc>May 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Graz</investigator_affiliation>
    <investigator_full_name>Harald Dobnig, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>September 25, 2015</submitted>
    <returned>October 27, 2015</returned>
    <submitted>October 5, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

